The Business Research Company published its CAR-T Therapy
Global Market Report 2020 which provides strategists, marketers and senior
management with the critical information they need to assess the global CAR-T
Therapy market. The report provides in-depth analysis of the impact of COVID-19
on the market, along with revised market numbers due to the effects of the
coronavirus.
The report covers the CAR-T therapy market’s segments- by
target antigen: CD19, CD22, others and by application: acute lymphoblastic
leukemia, diffuse large b-cell lymphoma, follicular lymphoma, chronic
lymphocytic leukemia, multiple myeloma, others.
View Complete Report:
CAR-T Therapy Global Market Report 2020 is the most
comprehensive report available on this market and will help gain a truly global
perspective as it covers 60 geographies. The chapter on the impact of COVID-19
gives valuable insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The chapter also covers
markets which have been positively affected by the pandemic.
The regional and country breakdowns section gives an
analysis of the market in each geography and the size of the market by region
and by country. It also compares the market’s historic and forecast growth. It
covers all the regions, key developed countries and major emerging markets. It
draws comparisons with country populations and economies to understand the
importance of the market by country and how this is changing. The major regions
included in the report are Asia-Pacific, Western Europe, Eastern Europe, North
America, South America, Middle East, and Africa.
The companies in the market are conducting clinical trials
to assess the ability of CAR-T therapy to treat multiple myeloma. Multiple
myeloma is a type of white blood cell cancer where the cancer cells accumulate
in the bone marrow and surrounds the healthy blood cells. CAR-T therapy is
being tested as a treatment for multiple myeloma. CAR-T cells are modified to
target the multiple myeloma causing cells to treat the relapsed or refractory
multiple myeloma (RRMM).
Few Points From Table
Of Content
1. Executive Summary
2. CAR-T therapy Market Characteristics
3. CAR-T therapy Market Size And Growth
4. CAR-T therapy Market Segmentation
5. CAR-T therapy Market Regional And Country Analysis
.......
25. CAR-T therapy Market Competitive Landscape And Company
Profiles
26. Key Mergers And Acquisitions In The CAR-T therapy Market
27. CAR-T therapy Market Trends And Strategies
28. CAR-T therapy Market Future Outlook and Potential
Analysis
29. Appendix
Request A Sample
Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2808&type=smp
Few Points From List
Of Tables
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F,
2025F, 2030F, $ Billion
Table 3: Global CAR-T therapy Market, Segmentation By Target
Antigen, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global CAR-T therapy Market, Segmentation By
Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 5: Global CAR-T therapy Market, Split By Region,
Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
………
Table 27: Kite Pharma Financial Performance
Table 28: Pfizer Inc Financial Performance
Table 29: Juno Therapeutics Financial Performance
Table 30: Celgene Corporation Financial Performance
About The Business
Research Company:
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in the UK, the US and India and a
network of trained researchers in 52 countries globally.
Contact Information:
The Business Research
Company
Europe: +44 207 1930
708
Asia: +91 8897263534
Americas: +1 315 623
0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
